adj. p	Adjusted p-value
AHR	Aryl hydrocarbon receptor
BC	Breast cancer
CEU-700	3,5-Dichlorophenyl-4-(2-oxoimidazolidin-1-yl)benzenesulfonate
CEU-818	3,4,5-Trimethoxyphenyl 4-(3-butyl-2-oxoimidazolidin-1-yl)benzenesulfonate
CEU-826	3,4,5-Trimethoxyphenyl 4-(2-oxo-3-pentylimidazolidin-1-yl)benzenesulfonate
CEU-829	3,4-Dimethoxyphenyl 4-(2-oxo-3-pentylimidazolidin-1-yl)benzenesulfonate
CEU-835	3-Chlorophenyl 4-(2-oxo-3-pentylimidazolidin-1-yl)benzenesulfonate
CEU-934	3-Iodophenyl 4-(2-oxo-3-pentylimidazolidin-1-yl)benzenesulfonate
CEU-938	3,5-Dichlorophenyl 4-(2-oxo-3-pentylimidazolidin-1-yl)benzenesulfonate
CYP	Cytochrome P450
CYP1A1	Cytochrome P450 1A1
ER+	Estrogen receptor-positive
FOXA1	Forkhead box protein A1
HDAC9	Histone deacetylase 9
HER2+	Human epidermal growth factor receptor 2 of positive
LFC	Log2-fold change
PAIB-SOs	Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates
PCA	Principal component analysis
PIB-SOs	Phenyl 4-(2-oxo-3-imidazolidin-1-yl)benzenesulfonates
PRKCH	Protein kinase C eta
RAB25	Ras-related protein 25
RHOV	Ras homolog family member V
TNBC	Triple-negative breast cancer